Andrew Galler
Stock Analyst at Morgan Stanley
(0.57)
# 4,081
Out of 5,182 analysts
25
Total ratings
33.33%
Success rate
-15.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrew Galler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Maintains: Equal-Weight | $34 → $36 | $28.52 | +26.23% | 14 | Nov 10, 2025 | |
| SLN Silence Therapeutics | Initiates: Equal-Weight | $18 | $7.29 | +146.91% | 1 | Dec 9, 2022 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Equal-Weight | $41 → $37 | $76.39 | -51.56% | 2 | Nov 29, 2022 | |
| IONS Ionis Pharmaceuticals | Maintains: Overweight | $57 → $56 | $75.45 | -25.78% | 2 | Nov 10, 2022 | |
| VIR Vir Biotechnology | Maintains: Underweight | $15 → $18 | $10.18 | +76.82% | 2 | Nov 4, 2022 | |
| PTCT PTC Therapeutics | Initiates: Equal-Weight | $54 | $65.49 | -17.54% | 1 | Sep 9, 2022 | |
| HALO Halozyme Therapeutics | Initiates: Overweight | $50 | $64.57 | -22.56% | 1 | Sep 9, 2022 | |
| ADCT ADC Therapeutics | Initiates: Outperform | $44 | $3.68 | +1,095.65% | 1 | Nov 9, 2021 | |
| MRNA Moderna | Initiates: Outperform | $304 | $47.30 | +542.71% | 1 | Nov 9, 2021 |
Immunocore Holdings
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $34 → $36
Current: $28.52
Upside: +26.23%
Silence Therapeutics
Dec 9, 2022
Initiates: Equal-Weight
Price Target: $18
Current: $7.29
Upside: +146.91%
Arrowhead Pharmaceuticals
Nov 29, 2022
Maintains: Equal-Weight
Price Target: $41 → $37
Current: $76.39
Upside: -51.56%
Ionis Pharmaceuticals
Nov 10, 2022
Maintains: Overweight
Price Target: $57 → $56
Current: $75.45
Upside: -25.78%
Vir Biotechnology
Nov 4, 2022
Maintains: Underweight
Price Target: $15 → $18
Current: $10.18
Upside: +76.82%
PTC Therapeutics
Sep 9, 2022
Initiates: Equal-Weight
Price Target: $54
Current: $65.49
Upside: -17.54%
Halozyme Therapeutics
Sep 9, 2022
Initiates: Overweight
Price Target: $50
Current: $64.57
Upside: -22.56%
ADC Therapeutics
Nov 9, 2021
Initiates: Outperform
Price Target: $44
Current: $3.68
Upside: +1,095.65%
Moderna
Nov 9, 2021
Initiates: Outperform
Price Target: $304
Current: $47.30
Upside: +542.71%